StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) income statement

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$122.86+1.94 (+1.60%)

Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –

Haemonetics Corp income statement

Ratios

Latest available, balances at Jun 27, 2026

Profitability, TTM

Gross margin
59.0%
Operating margin
11.9%
Net margin
7.1%
Return on equity, FY2026
12.0%

Financial strength

Current ratio
3.08
Debt to equity
1.40
Debt to assets
49.6%
Cash to current liabilities
84.9%

Valuation

P/E ratio
59.9
Price to sales
4.13
Price to book
6.68
Dividend yield
–

See a number that looks wrong?